Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052).
J Gynecol Oncol
; 32(6): e90, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-34431258
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Platinum
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Female
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Gynecol Oncol
Year:
2021
Document type:
Article
Country of publication: